Clinical Trial Update: Phase I/II Clinical Trial of NP41 for Cranial Nerve Fluorescence Imaging [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial update for NP41 evaluating cranial nerve fluorescence imaging, with Phase 1 and Phase 2 ongoing for cranial nerve injuries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cranial Nerve Injuries

Drugs mentioned

• NP41

Snippet

Sponsor: Peking University Third Hospital | Conditions: Cranial Nerve Injuries | Phase 1, Phase 2 | Status: UNKNOWN